Question 1

What is the catalog number for C14orf22 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)?

Accepted Answer

The catalog number for C14orf22 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) is 53602111.

Question 2

What sizes are available for C14orf22 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)?

Accepted Answer

C14orf22 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) is available in the following size(s): 3x 1.0 µg.

Question 3

Is C14orf22 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) in stock?

Accepted Answer

C14orf22 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this product species cross-reactive?

Accepted Answer

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.

Question 5

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Question 6

How many freeze-thaw cycles can this product tolerate?

Accepted Answer

We recommend aliquoting the product upon receipt to avoid repeated freeze-thaw cycles, which can reduce activity and stability. This is your responsibility once the product has been delivered.

C14orf22 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

Product Specifications

Gene Name

Reactivity

Vector Name

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Human TFPI Protein, His Tag (active enzyme)

MUC16 / CA125 (Ovarian Carcinoma Marker) (MUC16/1860), CF647 conjugate, 0.1mg/mL

Human B7-1/CD80 ELISA Kit PicoKine®

PD1, Mouse (RMP1-14), CF594 conjugate, 0.1mg/mL

SOX9 / SRY-box 9 (SOX9/2398), CF640R conjugate, 0.1mg/mL

RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), 0.2mg/mL